Viewing Study NCT06484400



Ignite Creation Date: 2024-07-17 @ 11:02 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06484400
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-06-26

Brief Title: Cognitive Behavioral Therapy Versus Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms
Sponsor: Istanbul Nisantasi University
Organization: Istanbul Nisantasi University

Study Overview

Official Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms Controlled Randomized Study
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Title Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms A Controlled Randomized Study

Principal Investigator Dr Metin Çınaroğlu Istanbul Nişantaşı University Department of Psychology

Study Duration October 2023 - Ongoing

Objective The study aims to compare the effectiveness of Cognitive Behavioral Therapy CBT and Ericksonian Hypnotherapy in alleviating symptoms of depression and anxiety among volunteers in Istanbul

Methods This randomized controlled trial will enroll healthy individuals aged 18-65 who exhibit symptoms of depression and anxiety but are not clinically diagnosed Participants will be randomly divided into three groups one receiving CBT another receiving Ericksonian Hypnotherapy and a control group receiving no therapeutic intervention Standard psychological assessment tools such as the Beck Depression Inventory and Beck Anxiety Inventory will be used to measure outcomes

Significance Depression and anxiety are prevalent psychological disorders that significantly impair quality of life Comparing these two therapeutic approaches may provide valuable insights into more effective psychological treatment strategies thereby enhancing patient care in mental health settings

Study Protocol

Recruitment 150 volunteers will be screened using socio-demographic forms and psychological assessments

Intervention Participants will undergo CBT or Ericksonian Hypnotherapy according to their group allocation while the control group will be observed without intervention

Evaluation Pre- and post-treatment assessments will gauge the therapys impact on depression and anxiety symptoms

Expected Outcome The study expects to demonstrate the relative efficacy of CBT and Ericksonian Hypnotherapy providing evidence to guide treatment choices for managing depression and anxiety symptoms
Detailed Description: Study Title Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms A Controlled Randomized Study

Principal Investigator Dr Metin Çınaroğlu Associate Professor Department of Psychology Istanbul Nişantaşı University

Co-Investigators

Expert Psychologist Dr Eda Yılmazer Department of Psychology Beykoz University

Psychologist Cemre Odabaşı Clinical Psychology Thesis Student Istanbul Nişantaşı University

Assoc Prof Dr Fadime Çınar Coordinator Faculty of Health Sciences Istanbul Nişantaşı University

Dr Selami Varol Ülker Department of Psychology Üsküdar University Prof Dr Gökben Hızlı Sayar Psychiatrist Department of Psychiatry Üsküdar University

Study Duration Start Date October 2023 - End Date Ongoing

Background and Rationale Depression and anxiety are common mental health conditions globally significantly impacting individuals quality of life Cognitive Behavioral Therapy CBT is widely recognized for its effectiveness in modifying dysfunctional thinking and behaviors associated with psychological disorders Ericksonian Hypnotherapy utilizing hypnotic suggestion and accessing unconscious processes offers a complementary approach This study aims to evaluate and compare the therapeutic efficacy of these interventions in non-clinically diagnosed yet symptomatic individuals

Objective To compare the effectiveness of Cognitive Behavioral Therapy and Ericksonian Hypnotherapy in reducing symptoms of depression and anxiety

Study Design This is a randomized controlled comparative trial involving three groups

CBT group 15 participants Ericksonian Hypnotherapy group 15 participants Waiting list control group 15 participants

Methods

Participants A total of 150 volunteers from Istanbul aged 18-65 displaying symptoms of depression and anxiety without a clinical diagnosis Screening will be conducted using socio-demographic forms the Beck Depression Inventory BDI and the Beck Anxiety Inventory BAI

Intervention Participants will be randomly assigned to receive either CBT or Ericksonian Hypnotherapy with each intervention being administered over 12 sessions Each session will be conducted in person and on a one-on-one basis lasting approximately one hour held once a week

Control Group Individuals in the control group will not receive any intervention during the study period but will be offered therapy sessions after the studys conclusion as compensation for their participation

Measurements Psychological assessments will be conducted at baseline and post-intervention using the BDI and BAI to measure changes in depression and anxiety symptoms

Data Analysis The effectiveness of the interventions will be analyzed using independent and paired t-tests to compare pre- and post-intervention scores within and between groups ANOVA will be utilized for comparing the three groups and effect sizes will be calculated to determine the clinical significance of the treatments

Ethical Considerations The study will adhere to the ethical standards of the Helsinki Declaration and has been approved by the Institutional Review Board of Istanbul Nişantaşı University numbered 20233 Informed consent will be obtained from all participants ensuring confidentiality and the right to withdraw from the study at any time without any consequences

Significance By directly comparing two distinct therapeutic modalities this study seeks to provide empirical evidence to inform clinical practices and potentially guide future psychological interventions aimed at treating depression and anxiety

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None